Moreover, a loss of stromal Cav-1 has been reported to be a predictor of early tumor recurrence, lymph node metastasis, tamoxifen resistance, and poor clinical outcome in human breast cancer patients [17]. The gene discussed is CAV1; the disease is breast carcinoma.